Sanofi
- Country
- 🇫🇷France
- Ownership
- Public
- Employees
- 87.9K
- Market Cap
- $141.3B
- Website
- http://www.sanofi.com
- Introduction
Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Vaccines. The Pharmaceuticals segment comprises the commercial operations of the following global franchises: specialty care, diabetes and cardiovascular, established prescription products and generics, and research, development, and production activities. The Consumer Healthcare segment includes the commercial operations for its Consumer Healthcare products. The Vaccines segment consists commercial operations of Sanofi Pasteur. The company was founded in 1973 and is headquartered in Paris, France.
Comparative Study Evaluating the Effects of Fexofenadine HCI 180 mg With Orange Juice Versus Placebo With Orange Juice in a Skin Wheal and Flare Challenge Model.
- Conditions
- Allergy
- First Posted Date
- 2007-10-23
- Last Posted Date
- 2011-01-11
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 36
- Registration Number
- NCT00547768
- Locations
- 🇺🇸
Sanofi-Aventis, Bridgewater, New Jersey, United States
Phase I Dose Finding Study of SSR97225 Given in Patients With Refractory Cancer
- First Posted Date
- 2007-10-22
- Last Posted Date
- 2009-04-17
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 6
- Registration Number
- NCT00547261
- Locations
- 🇺🇸
Sanofi-Aventis Administrative Office, Bridgewater, New Jersey, United States
Ketek in CAP / AECB in Ambulatory Adult Patients
- Conditions
- Community Acquired Pneumonia (CAP)Acute Exacerbation of Chronic Bronchitis (AECB)
- First Posted Date
- 2007-10-19
- Last Posted Date
- 2007-11-14
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 174
- Registration Number
- NCT00546676
Glulisine + Lantus in Type I Patients
- Conditions
- Diabetes Mellitus, Type 1
- First Posted Date
- 2007-10-19
- Last Posted Date
- 2009-06-15
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 142
- Registration Number
- NCT00546702
- Locations
- 🇷🇺
Sanofi-aventis, Moscow, Russian Federation
REASSURE: The Effect of Rimonabant on HbA1c in Overweight or Obese Patients With Type 2 Diabetes Not Adequately Controlled on 2 Oral Antidiabetic Agents
- First Posted Date
- 2007-10-18
- Last Posted Date
- 2010-12-10
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 358
- Registration Number
- NCT00546325
- Locations
- 🇦🇺
Sanofi-Aventis Administrative Office, North Ryde, Australia
A Phase I Study of Intravenous Aflibercept in Combination With Docetaxel in Japanese Cancer Patients
- First Posted Date
- 2007-10-17
- Last Posted Date
- 2013-10-16
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 12
- Registration Number
- NCT00545246
- Locations
- 🇯🇵
Sanofi-Aventis Investigational Site Number 392001, Sunto-Gun, Japan
🇯🇵Sanofi-Aventis Investigational Site Number 392002, Iruma-gun, Japan
Glulisine + Lantus in Type I Patients
- Conditions
- Diabetes Mellitus, Type 1
- First Posted Date
- 2007-10-17
- Last Posted Date
- 2009-10-16
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 60
- Registration Number
- NCT00545337
- Locations
- 🇺🇦
Sanofi-Aventis, Kiev, Ukraine
Activity and Safety of Oral Administration of SSR150106XB for the Reduction of Inflammation in Patients With Active Rheumatoid Arthritis
- First Posted Date
- 2007-10-17
- Last Posted Date
- 2017-08-08
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 79
- Registration Number
- NCT00545454
- Locations
- 🇺🇦
Sanofi-Aventis Administrative Office, Kiev, Ukraine
ROSPA - Record on Satisfaction of Patients With Actonel 35 mg Once a Week
- Conditions
- Osteoporosis
- First Posted Date
- 2007-10-16
- Last Posted Date
- 2009-09-25
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 7
- Registration Number
- NCT00544180
- Locations
- 🇮🇱
Sanofi-Aventis, Natanya, Israel
Dose Escalation Safety and Pharmacokinetic Study of AVE9633 as Single Agent in Relapsed/Refractory CD33-Positive Acute Myeloid Leukemia
- Conditions
- Myeloid Leukemia
- First Posted Date
- 2007-10-15
- Last Posted Date
- 2009-05-14
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 12
- Registration Number
- NCT00543972
- Locations
- 🇪🇸
Sanofi-Aventis Administrative Office, Barcelona, Spain